Correlation Between Hookipa Pharma and Corvus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Hookipa Pharma and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Corvus Pharmaceuticals.
Diversification Opportunities for Hookipa Pharma and Corvus Pharmaceuticals
-0.8 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Hookipa and Corvus is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Corvus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Hookipa Pharma and Corvus Pharmaceuticals
Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Corvus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Hookipa Pharma is 1.18 times less risky than Corvus Pharmaceuticals. The stock trades about -0.2 of its potential returns per unit of risk. The Corvus Pharmaceuticals is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 221.00 in Corvus Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 688.00 from holding Corvus Pharmaceuticals or generate 311.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hookipa Pharma vs. Corvus Pharmaceuticals
Performance |
| Timeline |
| Hookipa Pharma |
| Corvus Pharmaceuticals |
Hookipa Pharma and Corvus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hookipa Pharma and Corvus Pharmaceuticals
The main advantage of trading using opposite Hookipa Pharma and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.| Hookipa Pharma vs. Tff Pharmaceuticals | Hookipa Pharma vs. Eliem Therapeutics | Hookipa Pharma vs. Inhibrx | Hookipa Pharma vs. Enliven Therapeutics |
| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |